Search Results for: good news

Stem cell good news: Spinal Cord Injury Trial, CIRM, Grants, & More

Jan-Nolta-stem-cell-good-news-2

Stem cell good news time and more will be coming later this week. The stem cell and regenerative medicine world sometimes feels chaotic. Why? Because so much is going on both on the positive and negative sides of things. There is a whirlwind of activity and developments, and a tendency sometimes within our arena to […]

Stem cell good news: Spinal Cord Injury Trial, CIRM, Grants, & More Read More »

Stem cell therapy review of good news: UC Davis, Asterias, Cynata, Mesoblast, ViaCyte

VC-01-post-implant-final1-e1503703572933, viacyte

It’s a difficult, but very important road to conclusively prove that an investigational stem cell therapy is both safe and effective in order to get final approval FDA or equivalents in other countries. For this reason, it is beneficial to highlight even small, but positive steps forward including encouraging pre-clinical data. Today I’m doing a

Stem cell therapy review of good news: UC Davis, Asterias, Cynata, Mesoblast, ViaCyte Read More »

Stem cells Sunday brunch of good news, fun links, & cool papers

Liao-et-al-Figure-2D

Enjoy! A Sunday brunch for the brain of science news, helpful links, and notable new papers including on stem cells. News and links CBER Director Focuses on Flexibility to Advance Regenerative Medicines Lab-Grown Blood Stem Cells Produced at Last Transplanted stem cells become eggs in sterile mice Maryland fund awards $8.5 million for stem cell research Positively good news from Asterias

Stem cells Sunday brunch of good news, fun links, & cool papers Read More »

Stem cell good news as Asterias SCI trial to expand with strong safety data

Jake-Javier-CIRM-Photo

The stem cell clinic trial being run by Asterias Biotherapeutics for spinal cord injury (SCI) reported (via CIRM) some preliminary very good news as it is so far seems safe and will be expanded to involve more patients. In the next phase, reportedly “Asterias is now looking to enroll 5-8 patients for this 20 million

Stem cell good news as Asterias SCI trial to expand with strong safety data Read More »

Stem cell good news: CIRM funds new cutting edge studies

VC-01-post-implant-final1-e1503703572933, viacyte

CIRM announced recently the funding of a number of exciting new studies. ViaCyte received additional funding to support its development of its hESC-based pancreatic progenitor cell product PEC-Direct clinic trials. This work is very promising. CIRM also funded additional diabetes-related research by Humacyte on engineering blood vessels for use in dialysis, which is very creative. I

Stem cell good news: CIRM funds new cutting edge studies Read More »

Stem cell good news briefs: TiGenix, Asterias, CIRM, Awards, & More

TiGenix

There’s a growing stream of stem cell good news of late. Stem cell biotech, TiGenix, reported encouraging Phase 3 allogeneic results on stem cells. A big milestone. I can’t wait to see the actual data. Its product, Cx601, has so far been safe and effective for perianal fistulas in Crohn’s disease. See more from Alexey on this. CIRM has funded the largest

Stem cell good news briefs: TiGenix, Asterias, CIRM, Awards, & More Read More »

6 recent stem cell good news stories including on liver disease

IPSC-array

Ready for some stem cell good news? It can be difficult at times in a cutting edge field like stem cells in terms of keeping upbeat about hopes of rapid translation to help patients with real, proven therapies. It takes a long time, money, dedication, and even a bit of luck for the researchers and

6 recent stem cell good news stories including on liver disease Read More »